These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24598551)

  • 21. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease.
    Kanhai DA; Kappelle LJ; van der Graaf Y; Uiterwaal CS; Visseren FL;
    Int J Obes (Lond); 2012 May; 36(5):695-702. PubMed ID: 21712810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes.
    Franssens BT; Westerink J; van der Graaf Y; Nathoe HM; Visseren FLJ;
    Int J Cardiol; 2016 Nov; 222():72-77. PubMed ID: 27458826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative relation of general, central, and visceral adiposity measures for coronary artery calcium in subjects without previous coronary events.
    Ho JS; Cannaday JJ; Barlow CE; Willis B; Haskell WL; FitzGerald SJ
    Am J Cardiol; 2009 Oct; 104(7):943-6. PubMed ID: 19766761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
    Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
    Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
    van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socioeconomic environment and recurrent coronary events after initial myocardial infarction.
    Koren A; Steinberg DM; Drory Y; Gerber Y;
    Ann Epidemiol; 2012 Aug; 22(8):541-6. PubMed ID: 22658825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-myocardial infarction anxiety or depressive symptoms and risk of new cardiovascular events or death: a population-based longitudinal study.
    Larsen KK; Christensen B; Nielsen TJ; Vestergaard M
    Psychosom Med; 2014; 76(9):739-46. PubMed ID: 25373894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease.
    Medina-Inojosa JR; Batsis JA; Supervia M; Somers VK; Thomas RJ; Jenkins S; Grimes C; Lopez-Jimenez F
    Am J Cardiol; 2018 Apr; 121(8):903-909. PubMed ID: 29482851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indices of central and peripheral body fat: association with non-fatal acute myocardial infarction.
    Oliveira A; Rodríguez-Artalejo F; Severo M; Lopes C
    Int J Obes (Lond); 2010 Apr; 34(4):733-41. PubMed ID: 20065979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressive symptom dimensions and cardiac prognosis following myocardial infarction: results from the ENRICHD clinical trial.
    Bekke-Hansen S; Trockel M; Burg MM; Taylor CB
    Psychol Med; 2012 Jan; 42(1):51-60. PubMed ID: 21682949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events.
    de Jonge P; van den Brink RH; Spijkerman TA; Ormel J
    J Am Coll Cardiol; 2006 Dec; 48(11):2204-8. PubMed ID: 17161246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study.
    Gruson E; Montaye M; Kee F; Wagner A; Bingham A; Ruidavets JB; Haas B; Evans A; Ferrières J; Ducimetière PP; Amouyel P; Dallongeville J
    Heart; 2010 Jan; 96(2):136-40. PubMed ID: 19561364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).
    Gulliksson M; Burell G; Vessby B; Lundin L; Toss H; Svärdsudd K
    Arch Intern Med; 2011 Jan; 171(2):134-40. PubMed ID: 21263103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body fat measured by a near-infrared interactance device as a predictor of cardiovascular events: the FINRISK'92 cohort.
    Pajunen P; Jousilahti P; Borodulin K; Harald K; Tuomilehto J; Salomaa V
    Obesity (Silver Spring); 2011 Apr; 19(4):848-52. PubMed ID: 20966903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.